Segall Bryant & Hamill’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,910
| Closed | -$220K | – | 715 |
|
|
2023
Q1 | $220K | Sell |
18,910
-20,000
| -51% | -$233K | ﹤0.01% | 685 |
|
|
2022
Q4 | $413K | Sell |
38,910
-14,200
| -27% | -$151K | ﹤0.01% | 599 |
|
|
2022
Q3 | $516K | Buy |
53,110
+28,300
| +114% | +$275K | 0.01% | 573 |
|
|
2022
Q2 | $359K | Sell |
24,810
-13,416
| -35% | -$194K | ﹤0.01% | 633 |
|
|
2022
Q1 | $1M | Sell |
38,226
-492,511
| -93% | -$12.9M | 0.01% | 517 |
|
|
2021
Q4 | $21.1M | Sell |
530,737
-86,495
| -14% | -$3.43M | 0.19% | 136 |
|
|
2021
Q3 | $31M | Buy |
617,232
+8,951
| +1% | +$449K | 0.3% | 95 |
|
|
2021
Q2 | $33.8M | Buy |
608,281
+90,356
| +17% | +$5.02M | 0.33% | 86 |
|
|
2021
Q1 | $24.2M | Buy |
+517,925
| New | +$24.2M | 0.24% | 117 |
|